SCHEMBL957003

SCHEMBL957003

CCCCCCCCCCCCCCCCC(O)C(=O)OCCO

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.55
FFAR1 O14842 2/20 0.55
NAAA Q02083 1/20 0.46
ACHE P22303 1/20 0.44
ZDHHC7 Q9NXF8 1/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.42
THRB P10828 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790426 1.00 GPR84 (0.55) GPR84FFAR1NAAAACHEZDHHC7
SCHEMBL822393 1.00 GPR84 (0.55) GPR84FFAR1NAAAACHEZDHHC7
SCHEMBL13658517 1.00 GPR84 (0.55) GPR84FFAR1NAAAACHEZDHHC7
SCHEMBL821842 0.98 GPR84 (0.52) GPR84FFAR1NAAAACHEZDHHC7
Ethylene SCHEMBL299575 0.96 GPR84 (0.52) GPR84FFAR1NAAAACHEZDHHC7
SCHEMBL822143 0.92 ACHE (0.47) GPR84FFAR1NAAAACHEMEN1
Propene SCHEMBL141131 0.92 GPR84 (0.47) GPR84FFAR1NAAAACHEZDHHC7
SCHEMBL3804116 0.91 MGLL (0.55) GPR84FFAR1FFAR4
SCHEMBL3804114 0.91 MGLL (0.55) GPR84FFAR1FFAR4
SCHEMBL3804119 0.91 MGLL (0.55) GPR84FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4734923-A1 CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS L'OREAL (FR) 2026-05-06 EP claimed
US-20250275894-A1 STABLE FOAMED CLEANSING COMPOSITION AND METHODS OF USE L'OREAL (FR) 2025-09-04 US claimed
US-20250009628-A1 CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS L'OREAL (FR) 2025-01-09 US claimed
EP-4487915-A2 CAPSULE FORMULATIONS ChemoCentryx, Inc. (US) 2025-01-08 EP claimed
WO-2025006412-A1 CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS L'OREAL (FR) 2025-01-02 WO claimed
US-20240299306-A1 CAPSULE FORMULATIONS CHEMOCENTRYX, INC. 2024-09-12 US claimed
US-20220233453-A1 CAPSULE FORMULATIONS CHEMOCENTRYX, INC. 2022-07-28 US claimed
US-20200165136-A1 SCROLL COMPOSITE HAVING AMPHIPHILIC SUBSTANCE INSIDE AND METHOD FOR PREPARATION OF THE SAME INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) 2020-05-28 US claimed
CN-110885586-A Vegetable oil-based ink viscosity regulator and preparation method thereof 苏州丰倍生物科技有限公司 2020-03-17 CN claimed
US-9593204-B2 Branched polymeric emulsifiers LUBRIZOL ADVANCED MATERIALS, INC. (US) 2017-03-14 US claimed
EP-2249806-A2 RESVERATROL FORMULATIONS Sirtris Pharmaceuticals, Inc. (US) 2010-11-17 EP claimed
WO-2009089011-A2 RESVERATROL FORMULATIONS SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-16 WO claimed
EP-0705094-B1 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS CARSON PROD CO (US) 2000-05-24 EP claimed
EP-0705094-A4 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS AMINCO INC (US) 1996-08-07 EP claimed
EP-0705094-A1 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS CARSON PRODUCTS COMPANY (US) 1996-04-10 EP claimed
WO-1995000107-A1 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS AMINCO, INC. (US) 1995-01-05 WO claimed
EP-0444178-A4 MASCARA COMPOSITION 1992-07-08 EP claimed
EP-0444178-A1 MASCARA COMPOSITION REVLON, INC. (US) 1991-09-04 EP claimed
WO-1991004006-A1 MASCARA COMPOSITION REVLON, INC. (US) 1991-04-04 WO claimed
US-4988502-A Cosmetics, pigments treated with lecithin, film forming resin, a humectant REVLON, INC. (US) 1991-01-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275894-A1 STABLE FOAMED CLEANSING COMPOSITION AND METHODS OF USE DAGLB, MGLL, LIPC GPR84 1787/4885FFAR1 493/4885NAAA 763/4885
US-20250009628-A1 CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS DAGLB, DSG1, CUTA GPR84 2562/4885FFAR1 1770/4885NAAA 744/4885
US-20200165136-A1 SCROLL COMPOSITE HAVING AMPHIPHILIC SUBSTANCE INSIDE AND METHOD FOR PREPARATION OF THE SAME PSAP, SGMS2, SDCBP GPR84 2635/4885FFAR1 2894/4885NAAA 2163/4885
US-20220233453-A1 CAPSULE FORMULATIONS C5AR1, C1R, C5 GPR84 786/4885FFAR1 479/4885NAAA 2588/4885
US-20240299306-A1 CAPSULE FORMULATIONS C5AR1, C1R, C5 GPR84 786/4885FFAR1 479/4885NAAA 2588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.